johnson and johnson glp 1 & (JNJ) Focuses on Cancer Drugs, Shuns GLP-1 Mar glp1 #nutritioneducation #diabetescare #dietitiansoflinkedin #accreditedpractisingdietitian
Description
Molecular Formula: CHNO
Insurance coverage for GLP-1 medications varies significantly based on your plan, diagnosis, and BMI requirements
Two leading glucagon-like peptide-1 (GLP-1) receptor agonists for obesity and type 2 diabetes Novo Nordisk A/Ss semaglutide (Wegovy/Ozempic) and Eli Lilly and Co.s tirzepatide (Mounjaro/Zepbound) are advancing in China after taking the U.S
And for good reason, the science behind them is solid, and the results can be dramatic
A limited exception to market exclusivity exists for drugs on the FDAs shortage list, which indicates a drug in low supply
